Revance Therapeutics Inc.
RVNC
NSD
Sector: Healthcare
Industry: Biotechnology
7.24
USD
0.47
(6.94%)
Optionable: Yes Market Cap: 620 M 90-day average vol: 2,144,586
Previous close: 6.77 Open: 6.83 Bid: 7.03 Ask: 7.51
52 week range
5.72 37.98
Last updated: Monday 4th December 2023
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
🎉 Exciting news! 🎉
You are invited to join our Discord Channel.
Interact, learn, and grow with experts in the markets!
Join our DiscordValue
Valuation
Price per Sales TTM ($) | 12.42 |
Price per Book TTM ($) | -5.71 |
PE Ratio (TTM) | -2.00 |
Book Value per Share ($) | -1.21 |
5 Year PE Range | NA , NA |
Risk
Custom Beta One Year | 1.34 |
Custom Beta Three Years | 1.26 |
Beneish M Score | -2.07 |
Altman Z Score | -4.70 |
Call: 1-877-778-8358
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today
Get started today